# Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer

> **NCT00003592** · PHASE3 · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 230 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** methotrexate
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00003592
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-04-22
- **Primary completion:** 2000-08
- **Final completion:** 2004-03-02
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2023-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003592, "Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00003592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*